Danaher

Partial coverage
NYSE: DHRUnited StatesLife sciences and diagnostics
Investor relations
DOCUMENTS INDEXED1305 document categories
PRESENTATIONS27Results & investor updates
REPORTING CURRENCYUSDUS dollar

About Danaher

Danaher designs and manufactures products used in life sciences and diagnostics. Its businesses supply instruments, consumables and services that support research, biopharmaceutical development and clinical testing.

Visit investor relations
THE LATEST RESULTS PACKAGE

Q3 2026

Q3 2026

Read the results, explore the slides and follow the discussion.

ISSUER IR DOCUMENT LIBRARY

Explore IR materials 130

Checked 11 Nov 2026
DocumentFormatActions
Q3 2026
Q3 2026 — Press release
Press release·Danaher
PDF62 KB
DOCUMENT QUICK VIEW

Q3 2026 — Press release

Q3 2026 — Presentation
Presentation·Danaher
PDF635 KB
DOCUMENT QUICK VIEW

Q3 2026 — Presentation

PDF183 KB
DOCUMENT QUICK VIEW

Q3 2026 — Earnings supplement

PDF160 KB
DOCUMENT QUICK VIEW

Q3 2026 — Non-GAAP reconciliations

Q3 2026 — Form 10-Q
Quarterly report·Danaher
PDF346 KB
DOCUMENT QUICK VIEW

Q3 2026 — Form 10-Q

Q2 2026
Q2 2026 — Press release
Press release·Danaher
PDF57 KB
DOCUMENT QUICK VIEW

Q2 2026 — Press release

Q2 2026 — Presentation
Presentation·Danaher
PDF631 KB
DOCUMENT QUICK VIEW

Q2 2026 — Presentation

PDF192 KB
DOCUMENT QUICK VIEW

Q2 2026 — Earnings supplement

PDF158 KB
DOCUMENT QUICK VIEW

Q2 2026 — Non-GAAP reconciliations

Q2 2026 — Form 10-Q
Quarterly report·Danaher
PDF328 KB
DOCUMENT QUICK VIEW

Q2 2026 — Form 10-Q